Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family-led Banpu—closed flat in its trading debut on Thursday in New York after raising $270 million from its IPO that was ...

At the closing bell, BioAge’s stock stood at $18.31 for a 1.7% gain over its IPO price. Earlier, the stock had been up as much as 30%. BKV’s stock finished its first day of trading at $18 ...

Ceribell rang in a $180.3 million IPO last week, with its public debut on the Nasdaq coming in well above its first pricing goal of about $101 million and its stock price trading up about 47% ...

RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its own ambitions at $182 million. While Upstream had already disclosed ...

The U.S. IPO market maintains its steady pace, with a fresh set of companies looking to raise capital. With the recent better-than-expected U.S. September report on job additions signalling a ...

The IPO of Niva Bupa Health Insurance Company includes a fresh share sale of Rs 800 crore and an offer-for-sale (OFS) of up to 1,400 crore by its promoter entities amounting to Rs 1,400 crore.

But the filing to go public reveals that Pony’s board of directors recently slashed the minimum valuation for its IPO down to $4 billion. Pony also dropped its minimum target for what it wants ...

one of the people said, asking not to be identified discussing confidential information. Apotea’s IPO could raise $200 million to $300 million, the people said.

Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as soon as 2024, according to people with knowledge of the matter.

PTL Limited PTLE IPO will take place October, 09 on the NASDAQ exchange under the ticker PTLE. The company is offering shares at an expected price between $4.00 and $6.00 per share with an insider ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat ... 18.31 for a 1.7% gain over its IPO price.